img

Global Optic Neuropathy Management Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Optic Neuropathy Management Market Research Report 2024

The optic neuropathy management market is a segment of the healthcare industry that is focused on developing and distributing medical products and services for the treatment and management of optic neuropathy.
According to Mr Accuracy reports’s new survey, global Optic Neuropathy Management market is projected to reach US$ 6125.6 million in 2029, increasing from US$ 4300 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Optic Neuropathy Management market research.
The optic neuropathy management market is driven by the increasing prevalence of optic neuropathies, such as glaucoma and optic neuritis, and the growing aging population at higher risk of these conditions. Optic neuropathies can lead to irreversible vision loss and impairment, necessitating effective management strategies. Additionally, advancements in diagnostic technologies, such as Optical Coherence Tomography (OCT) and visual field testing, aid in early detection and monitoring of optic neuropathies, further fueling the demand for management options.However, the market also faces challenges, including the complex and multifactorial nature of optic neuropathies, which often require tailored treatments for individual patients. The efficacy of available therapies can vary, and there is a need for the development of more targeted and personalized treatments. Moreover, ensuring timely access to specialized eye care and treatments in all regions poses a challenge, particularly in underserved areas.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Optic Neuropathy Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Eli Lilly and Company
GSK
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Roche
Bayer AG
Sanofi S.A
Bristol-Myers Squibb Company
Segment by Type
Oral
Injectable

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Optic Neuropathy Management report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Optic Neuropathy Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Optic Neuropathy Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Optic Neuropathy Management Market Perspective (2018-2029)
2.2 Optic Neuropathy Management Growth Trends by Region
2.2.1 Global Optic Neuropathy Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Optic Neuropathy Management Historic Market Size by Region (2018-2024)
2.2.3 Optic Neuropathy Management Forecasted Market Size by Region (2024-2029)
2.3 Optic Neuropathy Management Market Dynamics
2.3.1 Optic Neuropathy Management Industry Trends
2.3.2 Optic Neuropathy Management Market Drivers
2.3.3 Optic Neuropathy Management Market Challenges
2.3.4 Optic Neuropathy Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Optic Neuropathy Management Players by Revenue
3.1.1 Global Top Optic Neuropathy Management Players by Revenue (2018-2024)
3.1.2 Global Optic Neuropathy Management Revenue Market Share by Players (2018-2024)
3.2 Global Optic Neuropathy Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Optic Neuropathy Management Revenue
3.4 Global Optic Neuropathy Management Market Concentration Ratio
3.4.1 Global Optic Neuropathy Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optic Neuropathy Management Revenue in 2022
3.5 Optic Neuropathy Management Key Players Head office and Area Served
3.6 Key Players Optic Neuropathy Management Product Solution and Service
3.7 Date of Enter into Optic Neuropathy Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Optic Neuropathy Management Breakdown Data by Type
4.1 Global Optic Neuropathy Management Historic Market Size by Type (2018-2024)
4.2 Global Optic Neuropathy Management Forecasted Market Size by Type (2024-2029)
5 Optic Neuropathy Management Breakdown Data by Application
5.1 Global Optic Neuropathy Management Historic Market Size by Application (2018-2024)
5.2 Global Optic Neuropathy Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Optic Neuropathy Management Market Size (2018-2029)
6.2 North America Optic Neuropathy Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Optic Neuropathy Management Market Size by Country (2018-2024)
6.4 North America Optic Neuropathy Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Optic Neuropathy Management Market Size (2018-2029)
7.2 Europe Optic Neuropathy Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Optic Neuropathy Management Market Size by Country (2018-2024)
7.4 Europe Optic Neuropathy Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Optic Neuropathy Management Market Size (2018-2029)
8.2 Asia-Pacific Optic Neuropathy Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Optic Neuropathy Management Market Size by Region (2018-2024)
8.4 Asia-Pacific Optic Neuropathy Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Optic Neuropathy Management Market Size (2018-2029)
9.2 Latin America Optic Neuropathy Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Optic Neuropathy Management Market Size by Country (2018-2024)
9.4 Latin America Optic Neuropathy Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Optic Neuropathy Management Market Size (2018-2029)
10.2 Middle East & Africa Optic Neuropathy Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Optic Neuropathy Management Market Size by Country (2018-2024)
10.4 Middle East & Africa Optic Neuropathy Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Optic Neuropathy Management Introduction
11.1.4 AbbVie Revenue in Optic Neuropathy Management Business (2018-2024)
11.1.5 AbbVie Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Detail
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Optic Neuropathy Management Introduction
11.2.4 Eli Lilly and Company Revenue in Optic Neuropathy Management Business (2018-2024)
11.2.5 Eli Lilly and Company Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Optic Neuropathy Management Introduction
11.3.4 GSK Revenue in Optic Neuropathy Management Business (2018-2024)
11.3.5 GSK Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Optic Neuropathy Management Introduction
11.4.4 Pfizer Inc. Revenue in Optic Neuropathy Management Business (2018-2024)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Optic Neuropathy Management Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Optic Neuropathy Management Business (2018-2024)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Bausch Health Companies Inc.
11.6.1 Bausch Health Companies Inc. Company Detail
11.6.2 Bausch Health Companies Inc. Business Overview
11.6.3 Bausch Health Companies Inc. Optic Neuropathy Management Introduction
11.6.4 Bausch Health Companies Inc. Revenue in Optic Neuropathy Management Business (2018-2024)
11.6.5 Bausch Health Companies Inc. Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Optic Neuropathy Management Introduction
11.7.4 Roche Revenue in Optic Neuropathy Management Business (2018-2024)
11.7.5 Roche Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Detail
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Optic Neuropathy Management Introduction
11.8.4 Bayer AG Revenue in Optic Neuropathy Management Business (2018-2024)
11.8.5 Bayer AG Recent Development
11.9 Sanofi S.A
11.9.1 Sanofi S.A Company Detail
11.9.2 Sanofi S.A Business Overview
11.9.3 Sanofi S.A Optic Neuropathy Management Introduction
11.9.4 Sanofi S.A Revenue in Optic Neuropathy Management Business (2018-2024)
11.9.5 Sanofi S.A Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Optic Neuropathy Management Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Optic Neuropathy Management Business (2018-2024)
11.10.5 Bristol-Myers Squibb Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Optic Neuropathy Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Optic Neuropathy Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Optic Neuropathy Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Optic Neuropathy Management Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Optic Neuropathy Management Market Share by Region (2018-2024)
Table 8. Global Optic Neuropathy Management Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Optic Neuropathy Management Market Share by Region (2024-2029)
Table 10. Optic Neuropathy Management Market Trends
Table 11. Optic Neuropathy Management Market Drivers
Table 12. Optic Neuropathy Management Market Challenges
Table 13. Optic Neuropathy Management Market Restraints
Table 14. Global Optic Neuropathy Management Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Optic Neuropathy Management Market Share by Players (2018-2024)
Table 16. Global Top Optic Neuropathy Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Optic Neuropathy Management as of 2022)
Table 17. Ranking of Global Top Optic Neuropathy Management Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Optic Neuropathy Management Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Optic Neuropathy Management Product Solution and Service
Table 21. Date of Enter into Optic Neuropathy Management Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Optic Neuropathy Management Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Optic Neuropathy Management Revenue Market Share by Type (2018-2024)
Table 25. Global Optic Neuropathy Management Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Optic Neuropathy Management Revenue Market Share by Type (2024-2029)
Table 27. Global Optic Neuropathy Management Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Optic Neuropathy Management Revenue Market Share by Application (2018-2024)
Table 29. Global Optic Neuropathy Management Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Optic Neuropathy Management Revenue Market Share by Application (2024-2029)
Table 31. North America Optic Neuropathy Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Optic Neuropathy Management Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Optic Neuropathy Management Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Optic Neuropathy Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Optic Neuropathy Management Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Optic Neuropathy Management Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Optic Neuropathy Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Optic Neuropathy Management Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Optic Neuropathy Management Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Optic Neuropathy Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Optic Neuropathy Management Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Optic Neuropathy Management Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Optic Neuropathy Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Optic Neuropathy Management Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Optic Neuropathy Management Market Size by Country (2024-2029) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Optic Neuropathy Management Product
Table 49. AbbVie Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Eli Lilly and Company Company Detail
Table 52. Eli Lilly and Company Business Overview
Table 53. Eli Lilly and Company Optic Neuropathy Management Product
Table 54. Eli Lilly and Company Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 55. Eli Lilly and Company Recent Development
Table 56. GSK Company Detail
Table 57. GSK Business Overview
Table 58. GSK Optic Neuropathy Management Product
Table 59. GSK Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 60. GSK Recent Development
Table 61. Pfizer Inc. Company Detail
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. Optic Neuropathy Management Product
Table 64. Pfizer Inc. Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 65. Pfizer Inc. Recent Development
Table 66. Teva Pharmaceutical Industries Ltd. Company Detail
Table 67. Teva Pharmaceutical Industries Ltd. Business Overview
Table 68. Teva Pharmaceutical Industries Ltd. Optic Neuropathy Management Product
Table 69. Teva Pharmaceutical Industries Ltd. Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 70. Teva Pharmaceutical Industries Ltd. Recent Development
Table 71. Bausch Health Companies Inc. Company Detail
Table 72. Bausch Health Companies Inc. Business Overview
Table 73. Bausch Health Companies Inc. Optic Neuropathy Management Product
Table 74. Bausch Health Companies Inc. Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 75. Bausch Health Companies Inc. Recent Development
Table 76. Roche Company Detail
Table 77. Roche Business Overview
Table 78. Roche Optic Neuropathy Management Product
Table 79. Roche Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Bayer AG Company Detail
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Optic Neuropathy Management Product
Table 84. Bayer AG Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. Sanofi S.A Company Detail
Table 87. Sanofi S.A Business Overview
Table 88. Sanofi S.A Optic Neuropathy Management Product
Table 89. Sanofi S.A Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 90. Sanofi S.A Recent Development
Table 91. Bristol-Myers Squibb Company Company Detail
Table 92. Bristol-Myers Squibb Company Business Overview
Table 93. Bristol-Myers Squibb Company Optic Neuropathy Management Product
Table 94. Bristol-Myers Squibb Company Revenue in Optic Neuropathy Management Business (2018-2024) & (US$ Million)
Table 95. Bristol-Myers Squibb Company Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Optic Neuropathy Management Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Optic Neuropathy Management Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injectable Features
Figure 5. Global Optic Neuropathy Management Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Optic Neuropathy Management Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies and Drug Stores Case Studies
Figure 10. Optic Neuropathy Management Report Years Considered
Figure 11. Global Optic Neuropathy Management Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Optic Neuropathy Management Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Optic Neuropathy Management Market Share by Region: 2022 VS 2029
Figure 14. Global Optic Neuropathy Management Market Share by Players in 2022
Figure 15. Global Top Optic Neuropathy Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Optic Neuropathy Management as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Optic Neuropathy Management Revenue in 2022
Figure 17. North America Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Optic Neuropathy Management Market Share by Country (2018-2029)
Figure 19. United States Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Optic Neuropathy Management Market Share by Country (2018-2029)
Figure 23. Germany Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Optic Neuropathy Management Market Share by Region (2018-2029)
Figure 31. China Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Optic Neuropathy Management Market Share by Country (2018-2029)
Figure 39. Mexico Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Optic Neuropathy Management Market Share by Country (2018-2029)
Figure 43. Turkey Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Optic Neuropathy Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AbbVie Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 47. GSK Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 48. Pfizer Inc. Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 49. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 50. Bausch Health Companies Inc. Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 51. Roche Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 52. Bayer AG Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 53. Sanofi S.A Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Optic Neuropathy Management Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed